“At present, 13cRA, BC plus RP , and RP alone cannot be recommended for chemoprevention, and new, better agents are needed in this setting.”
“The clinical response rate of RP alone (20.0%) was significantly lower than that of BC plus RP (42.9%; P = .03).”